share_log

Janney Montgomery Scott LLC Takes $1.03 Million Position in IShares Genomics Immunology and Healthcare ETF (NYSEARCA:IDNA)

Janney Montgomery Scott LLC Takes $1.03 Million Position in IShares Genomics Immunology and Healthcare ETF (NYSEARCA:IDNA)

詹尼·蒙哥馬利·斯科特有限責任公司持有iShares基因組免疫學和醫療保健ETF(NYSEARCA: IDNA)的103萬美元頭寸
Defense World ·  2023/04/30 17:52

Janney Montgomery Scott LLC acquired a new stake in iShares Genomics Immunology and Healthcare ETF (NYSEARCA:IDNA – Get Rating) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 40,741 shares of the company's stock, valued at approximately $1,025,000. Janney Montgomery Scott LLC owned 0.66% of iShares Genomics Immunology and Healthcare ETF as of its most recent filing with the Securities and Exchange Commission (SEC).

根據向美國證券交易委員會(SEC)提交的最新13F表格,詹尼·蒙哥馬利·斯科特有限責任公司在第四季度收購了iShares Genomics Immunology and Healthcare ETF(NYSEARCA: IDNA — 獲取評級)的新股份。該機構投資者收購了該公司40,741股股票,價值約爲1,025,000美元。截至最近向美國證券交易委員會(SEC)提交文件,詹尼·蒙哥馬利·斯科特有限責任公司擁有iShares基因組免疫學和醫療保健ETF0.66%的股份。

Several other hedge funds and other institutional investors have also recently bought and sold shares of the stock. Westside Investment Management Inc. grew its holdings in iShares Genomics Immunology and Healthcare ETF by 200.0% during the third quarter. Westside Investment Management Inc. now owns 1,050 shares of the company's stock worth $21,212,000 after acquiring an additional 700 shares during the period. Vigilant Capital Management LLC acquired a new stake in iShares Genomics Immunology and Healthcare ETF during the fourth quarter worth about $25,000. Credit Suisse AG acquired a new stake in iShares Genomics Immunology and Healthcare ETF during the second quarter worth about $40,000. Finally, Flow Traders U.S. LLC acquired a new stake in iShares Genomics Immunology and Healthcare ETF during the third quarter worth about $303,000.

其他幾家對沖基金和其他機構投資者最近也買入和賣出了該股的股票。Westside Investment Management Inc. 在第三季度將其在iShares基因組免疫學和醫療保健ETF的持股量增加了200.0%。Westside Investment Management Inc. 在此期間又收購了700股股票後,現在擁有該公司1,050股股票,價值21.12萬美元。Vigilant Capital Management LLC在第四季度收購了iShares基因組免疫學和醫療保健ETF的新股份,價值約25,000美元。瑞士信貸股份公司在第二季度收購了iShares基因組免疫學和醫療保健ETF的新股份,價值約4萬美元。最後,Flow Traders U.S. LLC在第三季度收購了iShares Genomics免疫學和醫療保健ETF的新股份,價值約30.3萬美元。

Get
獲取
iShares Genomics Immunology and Healthcare ETF
iShares Genomics 免疫學和醫療保健 ETF
alerts:
警報:

iShares Genomics Immunology and Healthcare ETF Stock Up 0.8 %

iShares 基因組學免疫學和醫療保健 ETF 股票上漲0.8%

iShares Genomics Immunology and Healthcare ETF stock opened at $23.44 on Friday. The firm has a market cap of $145.33 million, a price-to-earnings ratio of 10.95 and a beta of 0.90. iShares Genomics Immunology and Healthcare ETF has a 52 week low of $22.09 and a 52 week high of $34.66. The business's 50-day moving average price is $23.62 and its 200 day moving average price is $25.59.

iShares 基因組免疫學和醫療保健ETF股票週五開盤價爲23.44美元。該公司的市值爲1.4533億美元,市盈率爲10.95,beta值爲0.90。iShares Genomics Immunology and Healthcare ETF的市值爲22.09美元,創52周高點34.66美元。該公司的50天移動平均價格爲23.62美元,其200天移動平均線價格爲25.59美元。

iShares Genomics Immunology and Healthcare ETF Company Profile

iShares 基因組學免疫學和醫療保健 ETF 公司簡介

(Get Rating)

(獲取評分)

The iShares Genomics Immunology and Healthcare ETF (IDNA) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund tracks a market-cap-selected and -weighted index of global stocks involved in genomics, immunology, and bioengineering. IDNA was launched on Jun 11, 2019 and is managed by BlackRock.

iShares基因組免疫學和醫療保健ETF(IDNA)是一家交易所交易基金,主要投資於基於特定主題的股票。該基金追蹤涉及基因組學、免疫學和生物工程的全球股票的市值精選和加權指數。IDNA 於 2019 年 6 月 11 日推出,由貝萊德管理。

Further Reading

進一步閱讀

  • Get a free copy of the StockNews.com research report on iShares Genomics Immunology and Healthcare ETF (IDNA)
  • MarketBeat Week in Review – 4/24 – 4/28
  • How to Invest in the Top Grocery Stocks for This Year
  • Array Technologies Brings Solar Flare To 2023 Earnings Forecast
  • Best Bank Stocks to Invest in Ahead of Rising Interest Rates
  • How to Invest in Farmland: 7 Simple Ways
  • 免費獲取 StockNews.com 關於 iShares 基因組免疫學和醫療保健 ETF (IDNA) 的研究報告的副本
  • MarketBeat 週迴顧 — 4 月 24 日 — 4 月 28 日
  • 如何投資今年最熱門的雜貨股
  • Array Technologies將太陽耀斑帶入
  • 在利率上升之前投資的最佳銀行股
  • 如何投資農田:7 種簡單方法

Want to see what other hedge funds are holding IDNA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for iShares Genomics Immunology and Healthcare ETF (NYSEARCA:IDNA – Get Rating).

想看看還有哪些對沖基金持有 IDNA 嗎? 訪問HoldingsChannel.com,獲取iShares基因組免疫學和醫療保健ETF(NYSEARCA: IDNA——獲取評級)的最新13F申報和內幕交易。

Receive News & Ratings for iShares Genomics Immunology and Healthcare ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares Genomics Immunology and Healthcare ETF and related companies with MarketBeat.com's FREE daily email newsletter.

每日接收iShares基因組免疫學和醫療保健ETF的新聞和評級 -在下面輸入您的電子郵件地址,通過Marketbeat.com的免費每日電子郵件時事通訊接收iShares Genomics Immunology and Healthcare ETF及相關公司的最新新聞和分析師評級的簡明每日摘要。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論